1. Home
  2. CNTY vs ELUT Comparison

CNTY vs ELUT Comparison

Compare CNTY & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNTY

Century Casinos Inc.

HOLD

Current Price

$0.83

Market Cap

36.0M

ML Signal

HOLD

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.73

Market Cap

42.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNTY
ELUT
Founded
1992
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.0M
42.5M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
CNTY
ELUT
Price
$0.83
$0.73
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $2.83
N/A
AVG Volume (30 Days)
★ 77.1K
75.0K
Earning Date
11-06-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
51.31
★ 146.77
EPS
N/A
★ N/A
Revenue
★ $430,529,000.00
$12,293,000.00
Revenue This Year
$3.19
N/A
Revenue Next Year
$0.57
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 10.82
N/A
52 Week Low
$0.78
$0.50
52 Week High
$2.38
$1.39

Technical Indicators

Market Signals
Indicator
CNTY
ELUT
Relative Strength Index (RSI) 18.08 36.52
Support Level N/A N/A
Resistance Level $1.33 $1.18
Average True Range (ATR) 0.07 0.05
MACD -0.02 -0.00
Stochastic Oscillator 16.06 6.76

Price Performance

Historical Comparison
CNTY
ELUT

About CNTY Century Casinos Inc.

Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has five reportable segments based on the geographical locations in which its casinos operate; US East, US Midwest, US West, Canada, and Poland.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: